Related content

Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles

By Minami Takafumi   Matsueda Satoko   Takedatsu Hiroko   Tanaka Masahiro   Noguchi Masanori   Uemura Hirotsugu   Itoh Kyogo   Harada Mamoru  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 5, 2007-05 ,pp. : 689-698

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the androgen receptor in hormone-refractory prostate cancer – new concepts

By Eder Iris E   Haag Petra   Bartsch Georg   Klocker Helmut  

Future Oncology, Vol. 1, Iss. 1, 2005-02 ,pp. : 93-101

Future Medicine

Access to resources Recommend Favorite

The contribution of dendritic cells to immune responses against urological cancers - T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

By Troy A.   Davidson P.   Atkinson C.   Hart D.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 1, 1998-01 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Two novel squamous cell carcinoma antigen-derived HLA-A*0201-binding peptides induce in vitro and in vivo CD8+ cytotoxic T lymphocyte responses

By                  

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1482-1492

Spandidos Publications

Access to resources Recommend Favorite

Management Strategies for Hormone-Refractory Prostate Cancer

By Attard Gerhardt   de Bono Johann S.   Parker Christopher C.   Horwich Alan  

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite